W J Urba Selected Research

Vincristine (Oncovin)

5/2000

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W J Urba Research Topics

Disease

9	Neoplasms (Cancer) 01/2019 - 02/2000
4	Melanoma (Melanoma, Malignant) 01/2019 - 04/2001
3	Breast Neoplasms (Breast Cancer) 08/2005 - 01/2000
2	Neoplasm Metastasis (Metastasis) 07/2003 - 04/2001
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2001
1	Anemia 04/2001
1	Neutropenia 04/2001
1	Thrombocytopenia (Thrombopenia) 04/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2000
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2000
1	Splenomegaly 05/2000
1	Lymphoma (Lymphomas) 05/2000
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2000
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2000

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 01/2004 - 06/2001
2	Cancer VaccinesIBA 07/2003 - 09/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2001 - 04/2001
1	NivolumabIBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2005
1	AnthracyclinesIBA 08/2005
1	Docetaxel (Taxotere)FDA Link 08/2005
1	AntigensIBA 01/2004
1	Fas Ligand Protein (Fas Ligand)IBA 06/2001
1	Granzymes (Granzyme)IBA 06/2001
1	PerforinIBA 06/2001
1	Topoisomerase I InhibitorsIBA 04/2001
1	Macrophage Colony-Stimulating FactorIBA 04/2001
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2001
1	Chemokine ReceptorsIBA 02/2001
1	ChemokinesIBA 02/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2000
1	L-SelectinIBA 09/2000
1	CytokinesIBA 09/2000
1	Interleukin-2 (IL2)IBA 09/2000
1	Etoposide (VP 16)FDA LinkGeneric 05/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2000
1	Vincristine (Oncovin)FDA LinkGeneric 05/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2000
1	Prednisone (Sone)FDA LinkGeneric 05/2000
1	RicinIBA 05/2000
1	Immunotoxins (Immunotoxin)IBA 05/2000
1	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2000
1	Methotrexate (Mexate)FDA LinkGeneric 05/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2000
1	Myelin Basic ProteinIBA 02/2000
1	To autoantigenIBA 02/2000
1	Complementary DNA (cDNA)IBA 01/2000
1	Amino Acids FDA Link 01/2000

Therapy/Procedure

4	Immunotherapy 07/2003 - 02/2000
3	Drug Therapy (Chemotherapy) 08/2005 - 05/2000
2	Therapeutics 01/2019 - 05/2000
1	Nephrectomy 04/2001
1	Aftercare (After-Treatment) 10/2000
1	PROMACE-CytaBOM protocol 05/2000
1	Combination Drug Therapy (Combination Chemotherapy) 05/2000
1	Operative Surgical Procedures 05/2000